Showing 1 - 5 results of 5 for search 'Öberg K', query time: 7.19s
Refine Results
-
1
ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors. by Pavel, M, Grossman, A, Arnold, R, Perren, A, Kaltsas, G, Steinmüller, T, de Herder, W, Nikou, G, Plöckinger, U, Lopes, J, Sasano, H, Buscombe, J, Lind, P, O'Toole, D, Oberg, K
Published 2010Journal article -
2
Gastroenteropancreatic neuroendocrine tumours. by Modlin, I, Oberg, K, Chung, D, Jensen, RT, de Herder, W, Thakker, R, Caplin, M, Delle Fave, G, Kaltsas, G, Krenning, E, Moss, S, Nilsson, O, Rindi, G, Salazar, R, Ruszniewski, P, Sundin, A
Published 2008Journal article -
3
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues by Wolin EM, Jarzab B, Eriksson B, Walter T, Toumpanakis C, Morse MA, Tomassetti P, Weber MM, Fogelman DR, Ramage J, Poon D, Gadbaw B, Li J, Pasieka JL, Mahamat A, Swahn F, Newell-Price J, Mansoor W, Öberg K
Published 2015-09-01
Article -
4
90Y-edotreotide for metastatic carcinoid refractory to octreotide. by Bushnell, D, O'Dorisio, T, O'Dorisio, MS, Menda, Y, Hicks, R, Van Cutsem, E, Baulieu, J, Borson-Chazot, F, Anthony, L, Benson, AB, Oberg, K, Grossman, AB, Connolly, M, Bouterfa, H, Li, Y, Kacena, K, LaFrance, N, Pauwels, SA
Published 2010Journal article -
5
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. by Klimstra, D, Modlin, I, Adsay, N, Chetty, R, Deshpande, V, Gönen, M, Jensen, RT, Kidd, M, Kulke, M, Lloyd, R, Moran, C, Moss, S, Oberg, K, O'Toole, D, Rindi, G, Robert, M, Suster, S, Tang, L, Tzen, C, Washington, M, Wiedenmann, B, Yao, J
Published 2010Journal article